본문 바로가기
KERD
논문KCI 등재

Optimizing Stem Cell Therapy after Ischemic Brain Injury

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류신경과학

초록

Stem cells have been used for regenerative and therapeutic purposes in a variety of diseases. In ischemic brain injury, preclinical studies have been promising, but have failed to translate results to clinical trials. We aimed to explore the application of stem cells after ischemic brain injury by focusing on topics such as delivery routes, regeneration efficacy, adverse effects, and in vivo potential optimization. PUBMED and Web of Science were searched for the latest studies examining stem cell therapy applications in ischemic brain injury, particularly after stroke or cardiac arrest, with a focus on studies addressing delivery optimization, stem cell type comparison, or translational aspects. Other studies providing further understanding or potential contributions to ischemic brain injury treatment were also included. Multiple stem cell types have been investigated in ischemic brain injury treatment, with a strong literature base in the treatment of stroke. Studies have suggested that stem cell administration after ischemic brain injury exerts paracrine effects via growth factor release, blood-brain barrier integrity protection, and allows for exosome release for ischemic injury mitigation. To date, limited studies have investigated these therapeutic mechanisms in the setting of cardiac arrest or therapeutic hypothermia. Several delivery modalities are available, each with limitations regarding invasiveness and safety outcomes. Intranasal delivery presents a potentially improved mechanism, and hypoxic conditioning offers a potential stem cell therapy optimization strategy for ischemic brain injury. The use of stem cells to treat ischemic brain injury in clinical trials is in its early phase; however, increasing preclinical evidence suggests that stem cells can contribute to the down-regulation of inflammatory phenotypes and regeneration following injury. The safety and the tolerability profile of stem cells have been confirmed, and their potent therapeutic effects make them powerful therapeutic agents for ischemic brain injury patients.

Abstract

Stem cells have been used for regenerative and therapeutic purposes in a variety of diseases. In ischemic brain injury, preclinical studies have been promising, but have failed to translate results to clinical trials. We aimed to explore the application of stem cells after ischemic brain injury by focusing on topics such as delivery routes, regeneration efficacy, adverse effects, and in vivo potential optimization. PUBMED and Web of Science were searched for the latest studies examining stem cell therapy applications in ischemic brain injury, particularly after stroke or cardiac arrest, with a focus on studies addressing delivery optimization, stem cell type comparison, or translational aspects. Other studies providing further understanding or potential contributions to ischemic brain injury treatment were also included. Multiple stem cell types have been investigated in ischemic brain injury treatment, with a strong literature base in the treatment of stroke. Studies have suggested that stem cell administration after ischemic brain injury exerts paracrine effects via growth factor release, blood-brain barrier integrity protection, and allows for exosome release for ischemic injury mitigation. To date, limited studies have investigated these therapeutic mechanisms in the setting of cardiac arrest or therapeutic hypothermia. Several delivery modalities are available, each with limitations regarding invasiveness and safety outcomes. Intranasal delivery presents a potentially improved mechanism, and hypoxic conditioning offers a potential stem cell therapy optimization strategy for ischemic brain injury. The use of stem cells to treat ischemic brain injury in clinical trials is in its early phase; however, increasing preclinical evidence suggests that stem cells can contribute to the down-regulation of inflammatory phenotypes and regeneration following injury. The safety and the tolerability profile of stem cells have been confirmed, and their potent therapeutic effects make them powerful therapeutic agents for ischemic brain injury patients.

참고문헌 (189)

  1. Borlongan CV, "Concise review: stem cell therapy for stroke patients:are we there yet?", Stem Cells Transl Med, 8, pp.983~988 (2019)
  2. Banerjee S, "Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke", Stem Cells Transl Med, 3, pp.1322~1330 (2014)
  3. Savitz SI, "Intravenous autologous bone marrow mononuclear cells for ischemic stroke", Ann Neurol, 70, pp.59~69 (2011)
  4. Prasad K, "Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial", Stroke, 45, pp.3618~3624 (2014)
  5. Hess DC, "Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial", Lancet Neurol, 16, pp.360~368 (2017)
  6. Krause M, "Cell-based therapies for stroke: are we there yet?", Front Neurol, 10, pp.656~ (2019)
  7. Geng W, "Exosomes from miRNA-126-modified ADSCs promotes functional recovery after stroke in rats by improving neurogenesis and suppressing microglia activation", Am J Transl Res, 11, pp.780~792 (2019)
  8. Liu K, "Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke", Microvasc Res, 123, pp.74~80 (2019)
  9. Levy ML, "Phase I", II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke, 2019, pp.50, 2835~2841
  10. Gong B, "Intravenous transplants of human adipose-derived stem cell protect the rat brain from ischemia-induced damage", J Stroke Cerebrovasc Dis, 28, pp.595~603 (2019)
  11. Mangin G, "Cell therapy for ischemic stroke : how to turn a promising preclinical research into a successful clinical story", Stem Cell Rev Rep, 15, pp.176~193 (2019)
  12. Spiliopoulos S, "Intra-arterial administration of cell-based biological agents for ischemic stroke therapy", Expert Opin Biol Ther, 19, pp.249~259 (2019)
  13. Vahidy FS, "Intravenous bone marrow mononuclear cells for acute ischemic stroke: safety, feasibility, and effect size from a phase I clinical trial", Stem Cells, 37, pp.1481~1491 (2019)
  14. Yu SP, "Optochemogenetic stimulation of transplanted iPS-NPCs enhances neuronal repair and functional recovery after ischemic stroke", J Neurosci, 39, pp.6571~6594 (2019)
  15. Zhang Y, "Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro", Brain Res, 1725, pp.146432~ (2019)
  16. Wang T, "Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest", Crit Care Med, 36(11 Suppl), pp.S486~S491 (2008)
  17. Zhou L, "Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia", Cell Death Dis, 8, pp.e2774~ (2017)
  18. Tang X, "Bone marrow mesenchymal stem cells repair the hippocampal neurons and increase the expression of IGF-1 after cardiac arrest in rats", Exp Ther Med, 14, pp.4312~4320 (2017)
  19. Fairbairn NG, "Augmenting peripheral nerve regeneration using stem cells : a review of current opinion", World J Stem Cells, 7, pp.11~26 (2015)
  20. Jiang L, "Stem cell transplantation for peripheral nerve regeneration : current options and opportunities", Int J Mol Sci, 18, pp.94~ (2017)
  21. Yang Y, "Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12cells", Neural Regen Res, 15, pp.464~472 (2020)
  22. Deng Y, "Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2", J Biol Eng, 13, pp.71~ (2019)
  23. Nalamolu KR, "Exosomes treatment mitigates ischemic brain damage but does not improve post-stroke neurological outcome", Cell Physiol Biochem, 52, pp.1280~1291 (2019)
  24. Qing L, "Exosomes and their microRNA cargo : new players in peripheral nerve regeneration", Neurorehabil Neural Repair, 32, pp.765~776 (2018)
  25. Thomi G, "Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury", Stem Cell Res Ther, 10, pp.105~ (2019)
  26. Jiang X, "Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery", Proc Natl Acad Sci U S A, 113, pp.13857~13862 (2016)
  27. Li G, "Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies", Expert Opin Drug Deliv, 15, pp.163~172 (2018)
  28. Mangraviti A, "Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival", Biomaterials, 100, pp.53~66 (2016)
  29. Zhang S, "Dietary phytochemical approaches to stem cell regulation", J Funct Foods, 66, pp.103822~ (2020)
  30. Baker CL, "Capturing totipotent stem cells", Cell Stem Cell, 22, pp.25~34 (2018)
  31. Dulak J, "Adult stem cells : hopes and hypes of regenerative medicine", Acta Biochim Pol, 62, pp.329~337 (2015)
  32. Jaenisch R, "Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming", Cell, 132, pp.567~582 (2008)
  33. Liu Y, "Epigenetic profiles signify cell fate plasticity in unipotent spermatogonial stem and progenitor cells", Nat Commun, 7, pp.11275~ (2016)
  34. Kooreman NG, "Tumorigenicity of pluripotent stem cells : biological insights from molecular imaging", J R Soc Interface, 7(Suppl 6), pp.S753~S763 (2010)
  35. Cefalo MG, "Human iPSC for therapeutic approaches to the nervous system : present and future applications", Stem Cells Int, 2016, pp.4869071~ (2016)
  36. Ambasudhan R, "Potential for cell therapy in Parkinson’s disease using genetically programmed human embryonic stem cellderived neural progenitor cells", J Comp Neurol, 522, pp.2845~2856 (2014)
  37. Tang Y, "Current progress in the derivation and therapeutic application of neural stem cells", Cell Death Dis, 8, pp.e3108~ (2017)
  38. Oh JH, "Comparative analysis of human embryonic stem cellderived neural stem cells as an in vitro human model", Int J Mol Med, 41, pp.783~790 (2018)
  39. Cheng Y, "Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats", Int J Clin Exp Pathol, 8, pp.2928~2936 (2015)
  40. Ryu S, "Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain", Neural Regen Res, 11, pp.298~304 (2016)
  41. Huang L, "Neural stem cell therapies and hypoxicischemic brain injury", Prog Neurobiol, 173, pp.1~17 (2019)
  42. Andres RH, "Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain", Brain, 134(Pt 6), pp.1777~1789 (2011)
  43. Bacigaluppi M, "Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms", Brain, 132(Pt 8), pp.2239~2251 (2009)
  44. Hicks C, "In vivo and in vitro characterization of the angiogenic effect of CTX0E03 human neural stem cells", Cell Transplant, 22, pp.1541~1552 (2013)
  45. Kalladka D, "Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study", Lancet, 388, pp.787~796 (2016)
  46. Zhang R, "Function of neural stem cells in ischemic brain repair processes", J Cereb Blood Flow Metab, 36, pp.2034~2043 (2016)
  47. Barry FP, "Mesenchymal stem cell transplantation for tissue repair", Semin Plast Surg, 19, pp.229~239 (2005)
  48. Li X, "Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model", Neuropsychiatr Dis Treat, 12, pp.1287~1293 (2016)
  49. Donega V, "Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury", Exp Neurol, 261, pp.53~64 (2014)
  50. Van Velthoven CT, "Mesenchymal stem cells as a treatment for neonatal ischemic brain damage", Pediatr Res, 71(4 Pt 2), pp.474~481 (2012)
  51. Chung TN, "Effect of adipose-derived mesenchymal stem cell administration and mild hypothermia induction on delayed neuronal death after transient global cerebral ischemia", Crit Care Med, 45, pp.e508~e515 (2017)
  52. Sugiyama Y, "Intravenous administration of bone marrowderived mesenchymal stem cell, but not adipose tissue-derived stem cell, ameliorated the neonatal hypoxic-ischemic brain injury by changing cerebral inflammatory state in rat", Front Neurol, 9, pp.757~ (2018)
  53. Liao L, "Heparin improves BMSC cell therapy : anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy", Theranostics, 7, pp.106~116 (2017)
  54. Liu XL, "Intracranial transplantation of human adipose-derived stem cells promotes the expression of neurotrophic factors and nerve repair in rats of cerebral ischemia-reperfusion injury", Int J Clin Exp Pathol, 7, pp.174~183 (2013)
  55. Lam PK, "Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia", J Clin Neurosci, 71, pp.226~233 (2020)
  56. Ryu B, "Allogeneic adipose-derived mesenchymal stem cell sheet that produces neurological improvement with angiogenesis and neurogenesis in a rat stroke model", J Neurosurg, 132, pp.442~455 (2019)
  57. Yang Y, "Exosomes secreted by adipose-derived stem cells contribute to angiogenesis of brain microvascular endothelial cells following oxygen-glucose deprivation in vitro through microRNA-181b", TRPM7 axis, 2018, pp.65, 74~83
  58. Lin QM, "Bone marrow-derived mesenchymal stem cell transplantation attenuates overexpression of inflammatory mediators in rat brain after cardiopulmonary resuscitation", Neural Regen Res, 15, pp.324~331 (2020)
  59. Vahidinia Z, "The protective effect of bone marrow mesenchymal stem cells in a rat model of ischemic stroke via reducing the C-Jun N-terminal kinase expression", Pathol Res Pract, 215, pp.152519~ (2019)
  60. Sasaki Y, "Synergic effects of rehabilitation and intravenous infusion of mesenchymal stem cells after stroke in rats", Phys Ther, 96, pp.1791~1798 (2016)
  61. Hess DC, "A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke", Int J Stroke, 9, pp.381~386 (2014)
  62. Achyut BR, "Application of umbilical cord blood derived stem cells in diseases of the nervous system", J Stem Cell Res Ther, 4, pp.1000202~ (2014)
  63. Zhao Q, "Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke", Brain Res, 1624, pp.489~496 (2015)
  64. Liang CC, "The protective effect of human umbilical cord blood CD34+ cells and estradiol against focal cerebral ischemia in female ovariectomized rat : cerebral MR imaging and immunohistochemical study", PLoS One, 11, pp.e0147133~ (2016)
  65. Shiao ML, "Immunomodulation with human umbilical cord blood stem cells ameliorates ischemic brain injury : a brain transcriptome profiling analysis", Cell Transplant, 28, pp.864~873 (2019)
  66. Gonzales-Portillo GS, "Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier", Cell Transplant, 23, pp.531~539 (2014)
  67. Balaguer Rosello A, "Infections of the central nervous system after unrelated donor umbilical cord blood transplantation or human leukocyte antigen-matched sibling transplantation", Biol Blood Marrow Transplant, 23, pp.134~139 (2017)
  68. Gutiérrez-Fernández M, "Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke", Stem Cell Res Ther, 4, pp.11~ (2013)
  69. Hocum Stone LL, "Amelioration of ischemic brain injury in rats with human umbilical cord blood stem cells : mechanisms of action", Cell Transplant, 25, pp.1473~1488 (2016)
  70. Fischer UM, "Pulmonary passage is a major obstacle for intravenous stem cell delivery : the pulmonary first-pass effect", Stem Cells Dev, 18, pp.683~692 (2009)
  71. 정재우, "Familial Occurrence of Pulmonary Embolism after Intravenous, Adipose Tissue-Derived Stem Cell Therapy", Yonsei Medical Journal, 54(5), pp.1293~1296 (2013), 연세대학교의과대학[DOI]
  72. Leibacher J, "Biodistribution, migration and homing of systemically applied mesenchymal stem", stromal cells, 2016, pp.7, 7~
  73. Anjos-Afonso F, "In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions", J Cell Sci, 117(Pt 23), pp.5655~5664 (2004)
  74. Wang C, "Bone marrow mesenchymal stem cells ameliorate neurological deficits and bloodbrain barrier dysfunction after intracerebral hemorrhage in spontaneously hypertensive rats", Int J Clin Exp Pathol, 8, pp.4715~4724 (2015)
  75. Acosta SA, "Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke", Stroke, 46, pp.2616~2627 (2015)
  76. Hammadi AMA, "Intra-arterial injection of autologous bone marrow-derived mononuclear cells in ischemic stroke patients", Exp Clin Transplant, 17(Suppl 1), pp.239~241 (2019)
  77. Liang CC, "Effect of umbilical cord blood stem cells transplantation on bladder dysfunction induced by cerebral ischemia in rats", Taiwan J Obstet Gynecol, 55, pp.672~679 (2016)
  78. Walczak P, "Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia", Stroke, 39, pp.1569~1574 (2008)
  79. Karp JM, "Mesenchymal stem cell homing : the devil is in the details", Cell Stem Cell, 4, pp.206~216 (2009)
  80. Sackstein R, "Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone", Nat Med, 14, pp.181~187 (2008)
  81. Cui LL, "The cerebral embolism evoked by intraarterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity", Stem Cell Res Ther, 6, pp.11~ (2015)
  82. Cui LL, "Clumping and viability of bone marrow derived mesenchymal stromal cells under different preparation procedures : a flow cytometry-based in vitro study", Stem Cells Int, 2016, pp.1764938~ (2016)
  83. Argibay B, "Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia", Sci Rep, 7, pp.40758~ (2017)
  84. Cruz-Martinez P, "Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model", Cell Death Dis, 7, pp.e2223~ (2016)
  85. Lim JY, "Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia", Stem Cell Res Ther, 2, pp.38~ (2011)
  86. Al Fauzi A, "Clinical outcomes of repeated intraventricular transplantation of autologous bone marrow mesenchymal stem cells in chronic haemorrhagic stroke : a oneyear follow up", Open Neurol J, 11, pp.74~83 (2017)
  87. Fauzi AA, "Intraventricular transplantation of autologous bone marrow mesenchymal stem cells via ommaya reservoir in persistent vegetative state patients after haemorrhagic stroke : report of two cases & review of the literature", J Stem Cells Regen Med, 12, pp.100~104 (2016)
  88. Wang Z, "Intracerebroventricular administration of neural stem cells after cardiac arrest", Conf Proc IEEE Eng Med Biol Soc, 2019, pp.4213~4216 (2019)
  89. Bazhanov N, "Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs", Stem Cell Res Ther, 7, pp.27~ (2016)
  90. Zhang X, "Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy", J Neurosci Res, 92, pp.35~45 (2014)
  91. Cheng Z, "Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice", J Neuroinflammation, 15, pp.135~ (2018)
  92. Van Velthoven CT, "Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration", Brain Behav Immun, 24, pp.387~393 (2010)
  93. Chen SJ, "Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue", Stem Cells Dev, 19, pp.1757~1767 (2010)
  94. Baker EW, "Induced pluripotent stem cell-derived neural stem cell therapy enhances recovery in an ischemic stroke pig model", Sci Rep, 7, pp.10075~ (2017)
  95. Trapp T, "Hepatocyte growth factor", c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury, 2008, pp.283, 32244~32253
  96. Wagenaar N, "Repair of neonatal brain injury : bringing stem cell-based therapy into clinical practice", Dev Med Child Neurol, 59, pp.997~1003 (2017)
  97. Cunningham MG, "Preclinical evaluation of a novel intracerebral microinjection instrument permitting electrophysiologically guided delivery of therapeutics", Neurosurgery, 54, pp.1497~1507 (2004)
  98. Danielyan L, "Intranasal delivery of cells to the brain", Eur J Cell Biol, 88, pp.315~324 (2009)
  99. Galeano C, "The route by which intranasally delivered stem cells enter the central nervous system", Cell Transplant, 27, pp.501~514 (2018)
  100. Yu D, "Intranasal delivery of therapeutic stem cells to glioblastoma in a mouse model", J Vis Exp, 124, pp.55845~ (2017)
  101. Danielyan L, "Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease", Cell Transplant, 23(Suppl 1), pp.S123~S139 (2014)
  102. Balyasnikova IV, "Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors", Mol Ther, 22, pp.140~148 (2014)
  103. Chau MJ, "Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice", BMC Neurosci, 19, pp.20~ (2018)
  104. Dey M, "Intranasal oncolytic virotherapy with CXCR4-enhanced stem cells extends survival in mouse model of glioma", Stem Cell Reports, 7, pp.471~482 (2016)
  105. Donega V, "Intranasal mesenchymal stem cell treatment for neonatal brain damage : long-term cognitive and sensorimotor improvement", PLoS One, 8, pp.e51253~ (2013)
  106. Li YH, "Intranasal delivery of stem cells as therapy for central nervous system disease", Exp Mol Pathol, 98, pp.145~151 (2015)
  107. Wei N, "Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice", Cell Transplant, 22, pp.977~991 (2013)
  108. Ji G, "NF-κB signaling is involved in the effects of intranasally engrafted human neural stem cells on neurofunctional improvements in neonatal rat hypoxic-ischemic encephalopathy", CNS Neurosci Ther, 21, pp.926~935 (2015)
  109. Wei ZZ, "Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats", Cell Transplant, 24, pp.391~402 (2015)
  110. Ohshima M, "Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia", Brain Dev, 37, pp.376~386 (2015)
  111. Sarmah D, "Mesenchymal stem cell therapy in ischemic stroke : a meta-analysis of preclinical studies", Clin Pharmacol Ther, 103, pp.990~998 (2018)
  112. Jha AK, "Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels", Biomaterials, 47, pp.1~12 (2015)
  113. Hwang NS, "Controlled differentiation of stem cells", Adv Drug Deliv Rev, 60, pp.199~214 (2008)
  114. Stone LL, "Neural repair and neuroprotection with stem cells in ischemic stroke", Brain Sci, 3, pp.599~614 (2013)
  115. Jian WH, "Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration", Biomaterials, 174, pp.17~30 (2018)
  116. Liu S, "Strategies to optimize adult stem cell therapy for tissue regeneration", Int J Mol Sci, 17, pp.982~ (2016)
  117. Vu Q, "Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke", Neurology, 82, pp.1277~1286 (2014)
  118. Lin W, "Human umbilical cord mesenchymal stem cells preserve adult newborn neurons and reduce neurological injury after cerebral ischemia by reducing the number of hypertrophic microglia", macrophages, 2017, pp.26, 1798~1810
  119. Satani N, "World-wide efficacy of bone marrow derived mesenchymal stromal cells in preclinical ischemic stroke models : systematic review and meta-analysis", Front Neurol, 10, pp.405~ (2019)
  120. Wei L, "Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke", Prog Neurobiol, 157, pp.49~78 (2017)
  121. Saenger AK, "Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment", Clin Chem, 56, pp.21~33 (2010)
  122. Reis C, "Pathophysiology and the monitoring methods for cardiac arrest associated brain injury", Int J Mol Sci, 18, pp.129~ (2017)
  123. Chung TN, "Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage", Stem Cells Transl Med, 4, pp.178~185 (2015)
  124. Yu Y, "Mesenchymal stem cells derived from induced pluripotent stem cells play a key role in immunomodulation during cardiopulmonary resuscitation", Brain Res, 1720, pp.146293~ (2019)
  125. Lin QM, "Mesenchymal stem cells transplantation suppresses inflammatory responses in global cerebral ischemia : contribution of TNF-α-induced protein 6", Acta Pharmacol Sin, 34, pp.784~792 (2013)
  126. Wang JW, "Transplantation with hypoxia-preconditioned mesenchymal stem cells suppresses brain injury caused by cardiac arrest-induced global cerebral ischemia in rats", J Neurosci Res, 95, pp.2059~2070 (2017)
  127. Hirko AC, "Modulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cells", Stem Cells, 26, pp.2893~2901 (2008)
  128. Yamaguchi S, "Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke", J Cereb Blood Flow Metab, 38, pp.1199~1212 (2018)
  129. Dimmeler S, "Aging of progenitor cells: limitation for regenerative capacity?", J Am Coll Cardiol, 42, pp.2081~2082 (2003)
  130. Khan M, "Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice", J Cell Mol Med, 15, pp.1515~1527 (2011)
  131. Sart S, "Preconditioning stem cells for in vivo delivery", Biores Open Access, 3, pp.137~149 (2014)
  132. Ejtehadifar M, "The effect of hypoxia on mesenchymal stem cell biology", Adv Pharm Bull, 5, pp.141~149 (2015)
  133. Vertelov G, "High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA", Stem Cell Res Ther, 4, pp.5~ (2013)
  134. Horie N, "Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair", Stem Cells, 29, pp.274~285 (2011)
  135. Van Velthoven CT, "Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke", Stroke, 44, pp.1426~1432 (2013)
  136. Ou Y, "Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats", Brain Res, 1366, pp.217~225 (2010)
  137. Eckenstein FP, "Distribution of acidic and basic fibroblast growth factors in the mature, injured and developing rat nervous system", Prog Brain Res, 103, pp.55~64 (1994)
  138. Benz AH, "Early growth response-1 induction by fibroblast growth factor-1via increase of mitogen-activated protein kinase and inhibition of protein kinase B in hippocampal neurons", Br J Pharmacol, 160, pp.1621~1630 (2010)
  139. Tsai MJ, "Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model", Neuroscience, 305, pp.238~247 (2015)
  140. Ghazavi H, "Fibroblast growth factor type 1(FGF1)-overexpressed adipose-derived mesenchaymal stem cells(AD-MSC FGF1)induce neuroprotection and functional recovery in a rat stroke model", Stem Cell Rev Rep, 13, pp.670~685 (2017)
  141. Fatt M, "Metformin acts on two different molecular pathways to enhance adult neural precursor proliferation", self-renewal and differentiation, 2015, pp.5, 988~995
  142. Liu Y, "Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion", Neurosci Lett, 579, pp.46~51 (2014)
  143. Li J, "Effects of metformin in experimental stroke", Stroke, 41, pp.2645~2652 (2010)
  144. Jiang T, "Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy", Br J Pharmacol, 171, pp.3146~3157 (2014)
  145. Ould-Brahim F, "Metformin preconditioning of human induced pluripotent stem cell-derived neural stem cells promotes their engraftment and improves post-stroke regeneration and recovery", Stem Cells Dev, 27, pp.1085~1096 (2018)
  146. Yrjänheikki J, "A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window", Proc Natl Acad Sci U S A, 96, pp.13496~13500 (1999)
  147. Sakata H, "Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats : version 2", J Neurosci, 32, pp.3462~3473 (2012)
  148. Franco EC, "Modulation of microglial activation enhances neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical ischemia", Neurosci Res, 73, pp.122~132 (2012)
  149. Sharma RK, "Effect of oxidative preconditioning on neural progenitor cells", Brain Res, 1243, pp.19~26 (2008)
  150. George PM, "Electrical preconditioning of stem cells with a conductive polymer scaffold enhances stroke recovery", Biomaterials, 142, pp.31~40 (2017)
  151. Moon GJ, "Serum-mediated activation of bone marrow-derived mesenchymal stem cells in ischemic stroke patients : a novel preconditioning method", Cell Transplant, 27, pp.485~500 (2018)
  152. Yu SP, "Preconditioning strategy in stem cell transplantation therapy", Transl Stroke Res, 4, pp.76~88 (2013)
  153. Wei W, "Neuroprotection by mesenchymal stem cell(MSC)administration is enhanced by local cooling infusion(LCI)in ischemia", Brain Res, 1724, pp.146406~ (2019)
  154. Hwang S, "Combining human umbilical cord blood cells with erythropoietin enhances angiogenesis", neurogenesis and behavioral recovery after stroke, 2019, pp.10, 357~
  155. Karakoti A, "Redox-active radical scavenging nanomaterials", Chem Soc Rev, 39, pp.4422~4432 (2010)
  156. Zuo L, "Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells", Ther Adv Neurol Disord, 12, pp.1756286419859725~ (2019)
  157. Choi C, "The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model", Cytotherapy, 20, pp.820~829 (2018)
  158. Shen WB, "Magnetic enhancement of stem cell-targeted delivery into the brain following MR-guided focused ultrasound for opening the blood-brain barrier", Cell Transplant, 26, pp.1235~1246 (2017)
  159. Tollemar V, "Stem cells, growth factors and scaffolds in craniofacial regenerative medicine", Genes Dis, 3, pp.56~71 (2016)
  160. Luo L, "Effects of transplanted heparin-poloxamer hydrogel combining dental pulp stem cells and bFGF on spinal cord injury repair", Stem Cells Int, 2018, pp.2398521~ (2018)
  161. Kang P, "Novel biomaterials to study neural stem cell mechanobiology and improve cell-replacement therapies", Curr Opin Biomed Eng, 4, pp.13~20 (2017)
  162. Bolan F, "The potential of biomaterial-based approaches as therapies for ischemic stroke : a systematic review and meta-analysis of pre-clinical studies", Front Neurol, 10, pp.924~ (2019)
  163. Payne SL, "Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain", Biomaterials, 192, pp.309~322 (2019)
  164. Tseng TC, "An injectable, self-healing hydrogel to repair the central nervous system", Adv Mater, 27, pp.3518~3524 (2015)
  165. Jin K, "Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats", J Cereb Blood Flow Metab, 30, pp.534~544 (2010)
  166. González-Nieto D, "Hydrogels-assisted cell engraftment for repairing the stroke-damaged brain: chimera or reality", Polymers(Basel), 10, pp.184~ (2018)
  167. Zhuo F, "Injectable hyaluronan-methylcellulose composite hydrogel crosslinked by polyethylene glycol for central nervous system tissue engineering", Mater Sci Eng C Mater Biol Appl, 81, pp.1~7 (2017)
  168. Ballios BG, "A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation", Stem Cell Reports, 4, pp.1031~1045 (2015)
  169. Zhong J, "Hydrogel matrix to support stem cell survival after brain transplantation in stroke", Neurorehabil Neural Repair, 24, pp.636~644 (2010)
  170. Wollenberg AL, "Injectable polypeptide hydrogels via methionine modification for neural stem cell delivery", Biomaterials, 178, pp.527~545 (2018)
  171. Wolfs E, "Radiolabeling strategies for radionuclide imaging of stem cells", Stem Cell Rev Rep, 11, pp.254~274 (2015)
  172. Zhang F, "In vivo long-term tracking of neural stem cells transplanted into an acute ischemic stroke model with reporter gene-based bimodal MR and optical imaging", Cell Transplant, 26, pp.1648~1662 (2017)
  173. Holvoet B, "Increased understanding of stem cell behavior in neurodegenerative and neuromuscular disorders by use of noninvasive cell imaging", Stem Cells Int, 2016, pp.6235687~ (2016)
  174. Ma N, "Magnetic resonance imaging with superparamagnetic iron oxide fails to track the long-term fate of mesenchymal stem cells transplanted into heart", Sci Rep, 5, pp.9058~ (2015)
  175. Ngen EJ, "Imaging transplanted stem cells in real time using an MRI dual-contrast method", Sci Rep, 5, pp.13628~ (2015)
  176. Shen WB, "Human neural progenitor cells retain viability, phenotype, proliferation, and lineage differentiation when labeled with a novel iron oxide nanoparticle, Molday ION Rhodamine B", Int J Nanomedicine, 8, pp.4593~4600 (2013)
  177. Shen WB, "Cell-based therapy in TBI : magnetic retention of neural stem cells in vivo", Cell Transplant, 25, pp.1085~1099 (2016)
  178. Walczak P, "Real-time MRI for precise and predictable intraarterial stem cell delivery to the central nervous system", J Cereb Blood Flow Metab, 37, pp.2346~2358 (2017)
  179. Janowski M, "Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF", PLoS One, 9, pp.e97631~ (2014)
  180. Li W, "In vivo photoacoustic imaging of brain injury and rehabilitation by high-efficient near-infrared dye labeled mesenchymal stem cells with enhanced brain barrier permeability", Adv Sci(Weinh), 5, pp.1700277~ (2017)
  181. Haedicke IE, "An efficient T1 contrast agent for labeling and tracking human embryonic stem cells on MRI", Contrast Media Mol Imaging, 2019, pp.3475786~ (2019)
  182. Duan X, "Superparamagnetic iron oxide-loaded cationic polymersomes for cellular MR imaging of therapeutic stem cells in stroke", J Biomed Nanotechnol, 12, pp.2112~2124 (2016)
  183. Cheng SH, "Dynamic in vivo SPECT imaging of neural stem cells functionalized with radiolabeled nanoparticles for tracking of glioblastoma", J Nucl Med, 57, pp.279~284 (2016)
  184. Kim SM, "In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells : tropism for brain tumors and biodistribution", Int J Nanomedicine, 11, pp.13~23 (2015)
  185. Gervois P, "Stem cell-based therapies for ischemic stroke : preclinical results and the potential of imaging-assisted evaluation of donor cell fate and mechanisms of brain regeneration", Med Res Rev, 36, pp.1080~1126 (2016)
  186. Nagpal A, "Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke : a systematic review and meta-analysis", Stem Cell Res Ther, 8, pp.191~ (2017)
  187. Bhasin A, "Safety and feasibility of autologous mesenchymal stem cell transplantation in chronic stroke in Indian patients : a fouryear follow up", J Stem Cells Regen Med, 13, pp.14~19 (2017)
  188. Zheng W, "Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia", Brain Res, 1310, pp.8~16 (2010)
  189. Field JM, "Part 1 : executive summary : 2010American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care", Circulation, 122(18 Suppl 3), pp.S640~S656 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (20건)